Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
cancer
2
×
clinical trials
life sciences
national blog main
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
andrew berens
anirvan ghosh
astrazeneca
avapritinib
biogen
biotech
blueprint medicines
bluerock therapeutics
boston
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
cerovene
covid-19
crispr
deals
deciphera pharmaceuticals
deerfield management
detroit blog main
detroit top stories
durvalumab
editas medicine
europe blog main
europe top stories
fda
forty seven
fred hutch
gastrointestinal stromal tumor
general atlantic
What
announced
2
×
plans
2
×
acquisitions
approval
bio
blueprint
cancer
ceo
chasing
collabs
covid
daniel
deadly
deal
deciphera
drug
fda
filing
forms
gi
gilead
gilead’s
help
introduce
ipo
medicine
medicines
month
morning
o’day
pharamceuticals
roundup
sciences
seek
transformative
treats
tumor
type
years
Language
unset
Current search:
plans
×
announced
×
cancer
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
